Phase I single ascending dose study of T-4288 in healthy adult subjects

Trial Profile

Phase I single ascending dose study of T-4288 in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 22 May 2018

At a glance

  • Drugs Solithromycin (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Toyama Chemical
  • Most Recent Events

    • 21 Apr 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top